📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. (2020)

First Author: Moreno-Delgado D

Attributed to: Identifying Common Mechanisms of Neurodegeneration in Alzheimer's Disease, Amyotrophic lateral sclerosis and Parkinson's Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.51093

PubMed Identifier: 32513388

Publication URI: http://europepmc.org/abstract/MED/32513388

Type: Journal Article/Review

Volume: 9

Parent Publication: eLife

ISSN: 2050-084X